Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Document › Details

PerkinElmer, Inc.. (10/28/15). "Press Release: PerkinElmer Launches Signals for Translational. New Cloud-based Informatics Platform Supports Complete Precision Medicine Workflow". Waltham, MA.

Organisations Organisation PerkinElmer Inc. (NYSE: PKI)
  Group PerkinElmer (Group)
  Organisation 2 Albany Molecular Research Inc. (Nasdaq: AMRI)
  Group Albany Molecular (AMRI) (Group)
Products Product Signals™ for Translational cloud-based informatics platform
  Product 2 laboratory automation equipment
Persons Person Conway, Christopher (AMRI 201509 SVP Discovery + Development Services + Global Sales joined 2008 befofe Ortho-McNeil)
  Person 2 Madden, Karen (PerkinElmer 201406 President Informatics)

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of PerkinElmer Signals™ for Translational, a cloud-based data management, aggregation and analysis platform for pharmaceutical researchers. This new offering integrates experimental and clinical research data from many sources and relates the data to scientifically meaningful concepts. It also enables support for the complete precision medicine workflow, from data acquisition to biomarker discovery and validation.

Co-developed with top pharmaceutical companies, PerkinElmer Signals™ for Translational is designed to help researchers easily integrate experimental and clinical data from existing proprietary databases, private and public databases such as GEO and tranSMART, and connect with other enterprise systems. With more than 90 percent of the top 25 pharmaceutical companies engaged in translational research, PerkinElmer Signals™ for Translational supports greater collaboration and enables traditional scientists to increase the speed and efficiency of developing drugs tailored to patients' unique health needs.

"PerkinElmer Signals for Translational helps provide the foundation for new research and development opportunities," says Christopher Conway, Senior Vice President, Discovery and Development Services at Albany Molecular Research, Inc. (AMRI). "We are integrating the new solution into the cell::explorer instrumentation, a robotic automation platform for our high content screening applications located at AMRI's integrated drug discovery center in Buffalo, New York. This will significantly enhance our ability to quickly acquire, manage, integrate, and analyze large, complex data sets from the various translational platforms, ultimately accelerating knowledge and information pass-through for better and faster drug discovery."

PerkinElmer Signals™ for Translational provides access to data via a simplified user interface and a data model specifically designed to support translational research through the identification and management of biomarkers. It streamlines the sharing of data between pharmaceutical stakeholders and their partners in biotech, academic and contract research organizations.

"In the past, translational researchers could not intuitively engage with available data, which made searching for and accessing integrated data to identify and characterize biomarkers extremely challenging," said Karen Madden, President, Informatics at PerkinElmer. "This new translational platform's ability to enhance collaboration and eliminate silos between research and clinical data represents a significant step toward advancing precision medicine, ensuring optimal pairing between patients and drugs, and achieving better outcomes in human health."

PerkinElmer Signals™ for Translational is delivered in a Software as a Service (SaaS) model to help lower cost and provide flexibility and scalability for pharmaceutical IT operations. It is fully integrated with TIBCO Spotfire® self-service analytics software to enable translational scientists to more easily manage and explore the data from acquisition to analysis and visualization. Researchers can also:

> Store structured and unstructured data, including the output from bioinformatics or data scientists' processing pipelines
> Easily query, extract, identify, and store information for entities, like subjects or samples, that are relevant to translational medicine analysis; and
> Normalize the representation of stored data.

For more information, please visit

Follow us on Twitter @PKI_Informatics

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and safety of people and the environment. The Company reported revenue of approximately $2.2 billion in 2014, has about 7,700 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at

Alison Cizowski
+1 617-399-4914

Record changed: 2016-01-27


Picture Fairtec GmbH Worldwide Event Solutions 600x60px

More documents for PerkinElmer (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 600x60px

» top


Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 Germany June 120x240px Picture [LSE] – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture Berlin Partner HealthCapital Bionnale 2018 June Matchmaking 120x240px